| The CD70-CD27 axis in oncology: the new kids on the block T Flieswasser, A Van den Eynde, J Van Audenaerde, J De Waele, ... Journal of experimental & clinical cancer research 41 (1), 12, 2022 | 121 | 2022 |
| Cold atmospheric plasma-treated PBS eliminates immunosuppressive pancreatic stellate cells and induces immunogenic cell death of pancreatic cancer cells J Van Loenhout, T Flieswasser, L Freire Boullosa, J De Waele, ... Cancers 11 (10), 1597, 2019 | 111 | 2019 |
| Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer LF Boullosa, J Van Loenhout, T Flieswasser, J De Waele, C Hermans, ... Redox biology 42, 101949, 2021 | 90 | 2021 |
| Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation J Jacobs, V Deschoolmeester, K Zwaenepoel, T Flieswasser, C Deben, ... Oncoimmunology 7 (7), e1440167, 2018 | 60 | 2018 |
| Cellular senescence in cancer: clinical detection and prognostic implications A Domen, C Deben, J Verswyvel, T Flieswasser, H Prenen, M Peeters, ... Journal of Experimental & Clinical Cancer Research 41 (1), 360, 2022 | 53 | 2022 |
| Clinically relevant chemotherapeutics have the ability to induce immunogenic cell death in non-small cell lung cancer T Flieswasser, J Van Loenhout, L Freire Boullosa, A Van den Eynde, ... Cells 9 (6), 1474, 2020 | 48 | 2020 |
| Screening a broad range of solid and haematological tumour types for CD70 expression using a uniform IHC methodology as potential patient stratification method T Flieswasser, V Camara-Clayette, A Danu, J Bosq, V Ribrag, P Zabrocki, ... Cancers 11 (10), 1611, 2019 | 37 | 2019 |
| IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts A Van den Eynde, L Gehrcken, T Verhezen, HW Lau, C Hermans, ... Journal of Hematology & Oncology 17 (1), 8, 2024 | 19 | 2024 |
| Auranofin synergizes with the PARP inhibitor olaparib to induce ROS-mediated cell death in mutant p53 cancers L Freire Boullosa, J Van Loenhout, T Flieswasser, C Hermans, C Merlin, ... Antioxidants 12 (3), 667, 2023 | 17 | 2023 |
| Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models J Dewulf, T Flieswasser, T Delahaye, C Vangestel, A Miranda, ... EJNMMI Radiopharmacy and Chemistry 8 (1), 8, 2023 | 11 | 2023 |
| Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer T Flieswasser, A Van den Eynde, L Freire Boullosa, J Melis, C Hermans, ... Oncoimmunology 12 (1), 2192100, 2023 | 5 | 2023 |
| Nanobody targeting CD70 for immunoPET imaging in preclinical tumor models F Elvas, J Dewulf, T Flieswasser, T Delahaye, C Vanghestel, A Miranda, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| HARNESSING CD70-DIRECTED CAR NATURAL KILLER CELLS WITH IL-15 IS NECESSARY TO ERADICATE SOLID TUMOUR CELLS AND CANCER-ASSOCIATED FIBROBLASTS A Van Den Eynde, J Van Audenaerde, J De Waele, T Flieswasser, ... HUMAN GENE THERAPY 33 (7-8), A21-A21, 2022 | | 2022 |
| A novel combination strategy of anti-CD70 immunotherapy and chemotherapy in non-small cell lung cancer: the right partners in crime? T Flieswasser University of Antwerp, 2022 | | 2022 |
| Immunogenic properties of chemotherapeutic agents in the treatment of non-small cell lung cancer T Flieswasser, J Van Loenhout, LF Boullosa, A Van den Eynde, ... Cancer Research 80 (16_Supplement), 2414-2414, 2020 | | 2020 |
| PO-429 Identification of the right immunostimulatory chemotherapeutic partner for anti-CD70 immunotherapy in non-small cell lung cancer T Flieswasser, J Van Loenhout, K Zwaenepoel, C Rolfo, F Lardon, ... ESMO Open 3, A399, 2018 | | 2018 |
| Supplementary Materials: Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient … T Flieswasser, V Camara-Clayette, A Danu, J Bosq, V Ribrag, P Zabrocki, ... Age 12, 18, 0 | | |
